Journal of Clinical Endocrinology & Metabolism, Vol 61, 258-264, Copyright © 1985 by Endocrine Society

ARTICLES

Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses

RD Jackson, J Wortsman and WB Malarkey

This study reports the presence of a large molecular sized PRL as the major form of circulating immunoactive PRL in five women with idiopathic hyperprolactinemia and normal menses. Gel filtration patterns of serum from these patients revealed 98-100% predominance of a 150,000- to 160,000-dalton PRL in contrast to the predominance of the 22,000-dalton species in other hyperprolactinemic patients. This 150,000- to 160,000-dalton PRL was immunologically similar to the 22,000-dalton PRL, and its size on gel filtration was not altered using denaturing conditions. With reduction of disulfide bonds, there was a shift of the peak I PRL to smaller mol wt peptides. In addition, studies of one woman with idiopathic hyperprolactinemia and normal menses revealed preservation of 98% peak I predominance during physiological and pharmacological perturbations of PRL secretion. Finally, assay of the bioactivity of the large molecular sized PRL in the Nb2 rat lymphoma line revealed diminished activity compared to the 22,000-dalton species. This latter finding may help explain the maintenance of normal menses and relative lack of clinical signs in patients with this form of hyperprolactinemia.

This article has been cited by other articles:

				A. Leanos-Miranda, G. Cardenas-Mondragon, A. Ulloa-Aguirre, I. Isordia-Salas, A. Parra, and J. Ramirez-Peredo Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome Lupus, May 1, 2007; 16(5): 342 - 349. [Abstract] [PDF]

				A. Glezer, C. R. J. Soares, J. G. Vieira, D. Giannella-Neto, M. T. C. P. Ribela, V. Goffin, and M. D. Bronstein Human Macroprolactin Displays Low Biological Activity via Its Homologous Receptor in a New Sensitive Bioassay J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1048 - 1055. [Abstract] [Full Text] [PDF]

				A. Leanos-Miranda and G. Cardenas-Mondragon Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity Rheumatology, January 1, 2006; 45(1): 97 - 101. [Abstract] [Full Text] [PDF]

				J. Gibney, T. P. Smith, and T. J. McKenna The Impact on Clinical Practice of Routine Screening for Macroprolactin J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3927 - 3932. [Abstract] [Full Text] [PDF]

				N. Hattori, K. Ikekubo, Y. Nakaya, K. Kitagawa, and C. Inagaki Immunoglobulin G Subclasses and Prolactin (PRL) Isoforms in Macroprolactinemia Due to Anti-PRL Autoantibodies J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3036 - 3044. [Abstract] [Full Text] [PDF]

				M Garcia, M E Colombani-Vidal, C C Zylbersztein, A Testi, J Marcos, A Arturi, J Babini, and H E Scaglia Analysis of molecular heterogeneity of prolactin in human systemic lupus erythematosus Lupus, August 1, 2004; 13(8): 575 - 583. [Abstract] [PDF]

				A. M. Suliman, T. P. Smith, J. Gibney, and T. J. McKenna Frequent Misdiagnosis and Mismanagement of Hyperprolactinemic Patients before the Introduction of Macroprolactin Screening: Application of a New Strict Laboratory Definition of Macroprolactinemia Clin. Chem., September 1, 2003; 49(9): 1504 - 1509. [Abstract] [Full Text] [PDF]

				C. Mounier, J. Trouillas, B. Claustrat, R. Duthel, and B. Estour Macroprolactinaemia associated with prolactin adenoma Hum. Reprod., April 1, 2003; 18(4): 853 - 857. [Abstract] [Full Text] [PDF]

				T. P. Smith, A. M. Suliman, M. N. Fahie-Wilson, and T. J. McKenna Gross Variability in the Detection of Prolactin in Sera Containing Big Big Prolactin (Macroprolactin) by Commercial Immunoassays J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5410 - 5415. [Abstract] [Full Text] [PDF]

				S. Vallette-Kasic, I. Morange-Ramos, A. Selim, G. Gunz, S. Morange, A. Enjalbert, P.-M. Martin, P. Jaquet, and T. Brue Macroprolactinemia Revisited: A Study on 106 Patients J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 581 - 588. [Abstract] [Full Text] [PDF]

				M J Tansey and J A Schlechte Pituitary production of prolactin and prolactin-suppressing drugs Lupus, October 1, 2001; 10(10): 660 - 664. [Abstract] [PDF]

				F Blanco-Favela, K Chavez-Rueda, and A Leanos-Miranda Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus Lupus, October 1, 2001; 10(10): 757 - 761. [Abstract] [PDF]

				A. Leanos-Miranda, D. Pascoe-Lira, K. A. Chavez-Rueda, and F. Blanco-Favela Persistence of Macroprolactinemia Due to Antiprolactin Autoantibody before, during, and after Pregnancy in a Woman with Systemic Lupus Erythematosus J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2619 - 2624. [Abstract] [Full Text] [PDF]

				H. Leslie, C. H. Courtney, P. M. Bell, D. R. Hadden, D. R. McCance, P. K. Ellis, B. Sheridan, and A. B. Atkinson Laboratory and Clinical Experience in 55 Patients with Macroprolactinemia Identified by a Simple Polyethylene Glycol Precipitation Method J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2743 - 2746. [Abstract] [Full Text] [PDF]

				A M Jacobi, W Rohde, H-D Volk, T Dorner, G-R Burmester, and F Hiepe Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls Ann Rheum Dis, March 1, 2001; 60(3): 242 - 247. [Abstract] [Full Text] [PDF]

				D. Pascoe-Lira, G. Duran-Reyes, I. Contreras-Hernández, L. Manuel-Apolinar, F. Blanco-Favela, and A. Leaños-Miranda Frequency of Macroprolactinemia Due to Autoantibodies against Prolactin in Pregnant Women J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 924 - 929. [Abstract] [Full Text]

				C. Campino, C. Torres, S. Ampuero, S. Diaz, G.B. Gonzalez, and M. Seron-Ferre Bioactivity of prolactin isoforms: lactation and recovery of menses in nursing women Hum. Reprod., April 1, 1999; 14(4): 898 - 905. [Abstract] [Full Text] [PDF]

				J. G. H. Vieira, T. T. Tachibana, L. H. Obara, and R. M. B. Maciel Extensive Experience and Validation of Polyethylene Glycol Precipitation as a Screening Method for Macroprolactinemia Clin. Chem., August 1, 1998; 44(8): 1758 - 1759. [Full Text] [PDF]

				N. Hattori and C. Inagaki Anti-Prolactin (PRL) Autoantibodies Cause Asymptomatic Hyperprolactinemia: Bioassay and Clearance Studies of PRL-Immunoglobulin G Complex J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3107 - 3110. [Abstract] [Full Text] [PDF]